Kim Jeong Mee, Park So Jin, Sohn You Min, Lee Young Mee, Yang Catherine Seonghee, Gwak Hye Sun, Lee Byung Koo
College of Pharmacy & Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea ; Department of Pharmacy, Samsung Medical Center, Seoul, Korea.
Department of Pharmacy, Samsung Medical Center, Seoul, Korea.
Springerplus. 2014 Jan 17;3:34. doi: 10.1186/2193-1801-3-34. eCollection 2014.
To be utilized for the development of pharmacists' intervention service by determining factors which affect pharmacists' prescription interventions.
Patients who were admitted to intensive care units (ICUs) in internal medicine departments in Korea.
Data including age, gender, clinical departments, length of hospital stay, status of organ dysfunction, intervention status, frequently intervened drugs, and health care providers' questions were prospectively collected in ICUs in the department of internal medicine in a tertiary teaching hospital from January to December, 2012.
Primary outcome was factors which affect pharmacists' prescription interventions. Secondary outcomes included frequencies of the intervention, intervention acceptance rates, intervention issues, and frequently intervened drugs.
A total of 1,213 prescription interventions were made for 445 patients (33.1%) of the 1,344 patients that were analyzed. Length of hospital stay was significantly longer for the group that needed pharmacists' interventions (p < 0.001). Pharmacists' intervention requirements were significantly higher in patients with kidney dysfunction (p < 0.001). The percentage of intervention accepted was 96.8%, and interventions that were common were as follows (in order): clinical pharmacokinetic service, dosage or dosing interval changes, dosing time changes or dose changes, and total parenteral nutrition consultation. The five medications with the highest intervened frequency were (in order) vancomycin, famotidine, ranitidine, meropenem, and theophylline.
The need for pharmacists' prescription interventions was highest among patients with longer length of stay and patients with kidney dysfunction. Based on these findings, prescription intervention activities could be initiated with severely ill patients. The results could be utilized in countries which are planning to develop pharmacists' intervention service.
通过确定影响药剂师处方干预的因素,为药剂师干预服务的开展提供依据。
韩国内科重症监护病房(ICU)的患者。
前瞻性收集2012年1月至12月在一家三级教学医院内科ICU的患者数据,包括年龄、性别、临床科室、住院时间、器官功能障碍状态、干预状态、经常干预的药物以及医护人员的问题。
主要观察指标是影响药剂师处方干预的因素。次要观察指标包括干预频率、干预接受率、干预问题以及经常干预的药物。
在分析的1344例患者中,共对445例患者(33.1%)进行了1213次处方干预。需要药剂师干预的患者组住院时间明显更长(p<0.001)。肾功能不全患者对药剂师干预的需求明显更高(p<0.001)。干预接受率为96.8%,常见的干预如下(按顺序):临床药代动力学服务、剂量或给药间隔改变、给药时间改变或剂量改变以及全胃肠外营养咨询。干预频率最高的五种药物依次为万古霉素、法莫替丁、雷尼替丁、美罗培南和茶碱。
住院时间较长的患者和肾功能不全患者对药剂师处方干预的需求最高。基于这些发现,可以对重症患者开展处方干预活动。研究结果可用于计划开展药剂师干预服务的国家。